bluebird bio
BLUE
#10267
Rank
โ‚ฌ44.35 M
Marketcap
4,53ย โ‚ฌ
Share price
0.00%
Change (1 day)
-74.37%
Change (1 year)

EPS for bluebird bio (BLUE)

EPS in 2025 (TTM): -22,85ย โ‚ฌ

According to bluebird bio 's latest financial reports the company's current EPS (TTM) is -22,61ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -65,26ย โ‚ฌ an increase over its 2021 EPS that were of -217,82ย โ‚ฌ.

EPS history for bluebird bio from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-22,85ย โ‚ฌ
2022-65,26ย โ‚ฌ-70.04%
2021-217,82ย โ‚ฌ20.1%
2020-181,37ย โ‚ฌ-30.47%
2019-260,84ย โ‚ฌ34.11%
2018-194,49ย โ‚ฌ39.3%
2017-139,63ย โ‚ฌ8.5%
2016-128,69ย โ‚ฌ47.08%
2015-87,49ย โ‚ฌ169.66%
2014-32,45ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,81ย โ‚ฌ-107.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
0,91ย โ‚ฌ-104.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-0,35ย โ‚ฌ-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-0,47ย โ‚ฌ-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08203ย โ‚ฌ-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA